Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (2)

Subject

  • Drug Trafficking (157)
  • Synthetic drugs (113)
  • Arrests/Convictions - Major (84)
  • Guns/Weapons (72)
  • Guilty Plea (67)
  • Task Forces/Task Force Officers (41)
  • OCDETF/Task Force (34)
  • Seizures (Drugs/Property) (29)
  • Major Law Enforcement Operation (22)
  • Fentanyl Free America (15)
  • Fake Pills (14)
  • Prescription Drugs (14)
  • Money Laundering (11)
  • Pharmaceuticals/Pharmacists/Physicians (8)
  • Counterfeit Pills (7)
  • Overdose (7)
  • Fentanyl Awareness (5)
  • HIDTA (5)
  • Press Conferences (4)
  • Dark Web- Internet Trafficking (3)
  • Other (3)
  • Take Back Day (3)
  • Cartel (2)
  • Extraditions (2)
  • Intelligence Division - Intelligence Products (2)
  • International/Foreign Operations (2)
  • Outreach/Drug Prevention (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Campaigns (1)
  • Critical Incident (1)
  • Gangs (1)
  • One Pill Can Kill (1)
  • Diversion Division (11)

Drug Name

  • Amphetamines (1)
  • GHB (1)
  • Oxycodone (1)

Field Division

  • Atlanta (3)
  • Dallas (1)
  • El Paso (6)
  • Houston (5)
  • Los Angeles (2)
  • Louisville (1)
  • Miami (5)
  • New England (10)
  • New Jersey (3)
  • New Orleans (1)
  • New York (6)
  • Omaha (5)
  • Phoenix (2)
  • Rocky Mountain (2)
  • San Antonio (1)
  • San Francisco (7)
  • Seattle (7)
  • Sede (6)
  • St. Louis (8)
  • Washington, DC (4)
Clear All Results
View Archived Press Releases
11 Results - Showing 1 to 10
PRESS RELEASE

Orlando Pharmacy and Pharmacist Agree to Pay $50,000 to Settle Controlled Substances Act Violations

Orlando, FL – Plaza Pharmacy, LLC and Paul Ezeobinwa have agreed to pay the United States $50,000 to resolve allegations that they violated the Controlled Substances Act by improperly distributing schedule V drugs and committing multiple recordkeeping violations. U.S. Attorney Gregory W. Kehoe made the announcement. “Our Diversion investigators will...
PRESS RELEASE

Digital Health Company Founder/CEO & Clinical President Sentenced in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, DEA San Francisco Division Special Agent in Charge Bob Beris, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Warren County Physician and Nurse Practitioner Barred from DEA Registration for 20 Years For Prescribing Opioids Unlawfully

ALBANY, NEW YORK – Dr. Douglas Cline and nurse practitioner Laurie McKenna have agreed to pay $500,000 to resolve civil actions brought by the United States involving unlawful opioid prescribing practices and a fraudulent conveyance action against Dr. Cline, announced Drug Enforcement Administration New York Enforcement Division, Special Agent in...
PRESS RELEASE

National Health Care Fraud Takedown Leads to Forty-One Count Indictment of Pensacola Beach Man

Pensacola, Florida – Today, United States Attorney John P. Heekin announced criminal charges against Dr. Edward Scott Morrison, who is accused of illegally distributing and dispensing controlled substances. The charges filed in federal court are part of the Department of Justice’s 2026 National Health Care Fraud Takedown. U.S. Attorney Heekin...
PRESS RELEASE

Manhattan Men Charged with Conspiracy to Distribute Millions of Doses of Deadly Gamma-Butyrolactone (GBL), A Chemical Often Times Attributed to Sexual Assaults.

Special Agent in Charge of the New York Enforcement Division of the Drug Enforcement Administration (“DEA”), Farhana Islam, and United States Attorney for the Southern District of New York, Jay Clayton, announced today the unsealing of an Indictment charging MARK DYGDON and RODRIGO CASTRO in connection with the defendants’ distribution...
PRESS RELEASE

Brooklyn Woman Charged with Attempting to Steal Opioid Prescriptions from Hempstead Assisted Living Facility

MINEOLA, N.Y. – DEA New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Brooklyn woman was charged with attempted criminal possession of a controlled substance and forgery for allegedly sending falsified oxycodone prescriptions to a pharmacy to obtain...
PRESS RELEASE

New Yorkers Remove Over 14,000 Pounds of Unwanted Medications During DEA’s National Prescription Drug Take Back Day

NEW YORK, N.Y. – The United States Drug Enforcement Administration’s two New York Divisions, the New York Enforcement Division and the New York Task Force Division, announce the collection of over 14,000 pounds of unwanted, expired and/or medications. On April 25, 2026, the U.S. Drug Enforcement Administration joined 4,306 law...
PRESS RELEASE

Glen Head Doctor and His Son Charged with Illegally Selling Prescriptions for Controlled Substances

MINEOLA, N.Y. – Drug Enforcement Administration New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Glen Head doctor and his son were charged with allegedly selling dozens of prescriptions for opioids, amphetamines, and benzodiazepines without a legitimate medical...
PRESS RELEASE

Pensacola Pharmacist and Conspirator Charged with Illegal Drug Diversion Conspiracy

PENSACOLA, FLORIDA – Douglas Craig Reid Jr., 47, and Martrice Lamar Portis, 47, both of Pensacola, have been charged in federal court with conspiracy to unlawfully dispense and distribute controlled substances and to obtain controlled substances by fraud. The charges were announced by John P. Heekin, United States Attorney for...
PRESS RELEASE

Pensacola Women Plead Guilty to Illegal Drug Diversion

PENSACOLA, FLA – Alexandra M. Christensen, 31, Lindsay N. McCray (also known as Lindsay Rogers), 42, Heather T. Bradley (also known as Heather Thomas), 37, and Jennifer E. Purves, 39, all of Pensacola, Fla., pleaded guilty in federal court to charges in connection with the unlawful diversion of controlled substances...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster